Tagged with EY

Austria Erich Lehner, head of the life science branch at EY Austria, a worldwide leading consultancy firm, provides an insight into the current mandate of EY Austria as well as the services and one stop shop approach they provide for their three main focuses; Big Pharma, small to mid-size biotechs and…

Colombia Esteban Lizarazo, CEO of Amarey Group, one of the most vibrant Colombian success stories, shares his insights on the company’s aim to diversify, while introducing the group’s highly innovative business model consisting of world class logistics, high level education and development of close relationships with hospitals. Mr. Lizarazo having worked…

Switzerland With more than 20 years of experience working with the Swiss pharmaceutical sector, general manager Roland Laudenbacher explains that Honeywell Building Solutions has developed a true specialization in projects for pharma clients, including their own in house GMP validation services. To begin, could you please introduce Honeywell Business Solutions, and…

Switzerland EY’s Biotech Team Leader for the EMEIA region discusses the challenges Europe’s fragmented capital markets pose for biotech startups, the under-communicated benefits of doing an IPO on the Swiss stock exchange and the implications of the Actelion acquisition for the wider Swiss life sciences ecosystem. Among other things, you are…

Switzerland Switzerland has been long-established as one of the world’s most innovative countries and boasts a thriving ecosystem of startup biotechs. However, a slow and complex funding cycle means that an increasing number of Swiss biotechs are looking towards the US for funding; a trend that risks destabilising and weakening the…

Singapore According to A.T. Kearney Health Practice Partner Keith Lostaglio, Southeast Asia presents a significant growth opportunity to the pharma industry, and companies which develop effective digital platforms first will gain a significant competitive advantage in the coming years. Singapore’s unique economic role is rooted in openness and globalization. With that…

Ireland Sorcha McKenna, Partner at McKinsey & Company in Ireland, discusses the current trends in the Irish healthcare and life sciences sector, the potential behind both tech and integrated care for the industry, as well as some of the biggest evolutions she has seen during her 14-year career with the company.…

Ireland Aidan Meagher, Tax Partner & Irish Life Sciences Lead for EY Ireland, discusses EY’s extensive consulting work, including their efforts to promote entrepreneurship in Ireland, the changing landscape facing the medtech industry in the country as well as how Ireland can work to make itself an even more attractive destination…

Asia Despite underdevelopment in many facets; Southeast Asia is actually at the forefront of a digital revolution in healthcare; with digital solutions helping bring about more efficient, cost-effective, and tailored patient care. “Cloud-based technology, mobile enablement and fees for service models will lead to faster deployment and increased benefits for patients.…

Singapore The Asia-Pacific region is a vast geographic area, home to almost half of the world’s population and numerous emerging and developed markets with great investment potential for healthcare and life sciences companies. However, the degree of diversity within Asia-Pacific creates formidable challenges for MNCs operating in the region. “APAC is…

Singapore Martin Dewhurst of the Global Pharmaceuticals and Medical Products Practice at McKinsey & Company provides his view of the Asia Pacific Medtech Forum 2016 in Singapore and elaborates on the prominent trends for the industry in the region. What have been your first impressions of the MedTech Forum and your…

Pharma The executive director of the American Chamber of Commerce in the Czech Republic discusses measuring the impact that healthcare policy changes have on the healthy life years of Czechs. Furthermore, he identifies the Czech people as a most important asset which sets the nation apart from its neighbors. The AmCham…